From yesterday’s PR Newswire press release:
Mind Medicine (MindMed) Inc. (NEO: MMEDOTCQB: MMEDF), is supporting and collaborating on a Phase 2 clinical trial evaluating LSD for the treatment of cluster headaches at University Hospital Basel's Liechti Lab. The Phase 2 trial began recruiting patients in early January and has commenced treating patients with LSD.
The idea of treating cluster headaches with psychedelics isn’t new—people have been experimenting with it for decades—but there hasn’t been much research conducted on it yet. I’m curious to see how this trial turns out and hope that we see more research in this area soon.